首页> 外文OA文献 >Targeting of Tumor Cells by Cell Surface Urokinase Plasminogen Activator-dependent Anthrax Toxin

【2h】

Targeting of Tumor Cells by Cell Surface Urokinase Plasminogen Activator-dependent Anthrax Toxin

机译：细胞表面尿激酶纤溶酶原激活剂依赖性炭疽毒素靶向肿瘤细胞

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Shihui Liu; Thomas H. Bugge; Stephen H. Leppla;
展开▼
作者单位

展开▼
年度 2001
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Tumor therapy with a urokinase plasminogen activator-activated anthrax lethal toxin alone and in combination with paclitaxel [J] . WeinA.N., LiuS., ZhangY., Investigational new drugs. . 2013,第1期

机译：单独用尿激酶纤溶酶原激活物激活的炭疽致死毒素联合紫杉醇进行肿瘤治疗
2. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis [J] . Padmaja Tummalapalli, Christopher S. Gondi, Dzung H. Dinh, International journal of oncology . 2007,第1期

机译：RNA干扰介导的IOMM-lee恶性脑膜瘤细胞系中尿激酶纤溶酶原激活剂受体和基质金属蛋白酶9基因表达的靶向抑制肿瘤生长，肿瘤细胞侵袭和血管生成
3. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of e-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing met [J] . Rosanna Paciucci Maya R Vila Teresa Adell Victor M Diaz et al The American Journal of Pathology . 1998,第1期

机译：尿激酶纤溶酶原激活物/尿激酶纤溶酶原激活物受体系统的激活和e-钙粘着蛋白的重新分布与肝细胞生长因子诱导的胰腺癌细胞过度表达的运动有关
4. Inhibition of the Tumor-Associated Urokinase-Type Plasminogen Activation System: Effects of High-Level Synthesis of Soluble Urokinase Receptor in Ovarian and Breast Cancer Cells In Vitro and In Vivo [C] . Viktor Magdolen International Meeting on Molecular Staging on Cancer . 2003

机译：抑制肿瘤相关的尿激酶型纤溶酶原激活系统：高水平合成在体外和体内卵巢癌细胞中可溶性尿激酶受体的影响
5. Estrogen receptor beta: Influence on urokinase-type plasminogen activator in vascular smooth muscle cells. [D] . Paradis, Madeleine Aimee. 2003

机译：雌激素受体β：对血管平滑肌细胞中尿激酶型纤溶酶原激活剂的影响。
6. Tumor therapy with a urokinase plasminogen activator-activated anthrax lethal toxin alone and in combination with paclitaxel [O] . Alexander N. Wein, Shihui Liu, Yi Zhang, -1

机译：肿瘤治疗用尿激酶纤溶酶原激活剂活化的Anthrax致命毒素单独与紫杉醇组合
7. Sensitivity of acute myeloid leukemia cells to the dual targeting of the urokinase plasminogen activator and the MAPK pathway by a urokinase-activated anthrax lethal toxin. (c2013) [O] . Bekdash Amira 2013

机译：急性髓细胞性白血病细胞对尿激酶激活的炭疽致死毒素对尿激酶纤溶酶原激活物和MAPK途径双重靶向的敏感性。（c2013）
8. Cellular Mechanisms Regulating Urokinase-Type Plasminogen Activator in Hormone Refractory Prostate Cancer: A Novel Therapeutic Target [R] . Gallick, G. E. 2004

机译：调节激素难治性前列腺癌中尿激酶型纤溶酶原激活物的细胞机制：一种新的治疗靶点

Targeting of Tumor Cells by Cell Surface Urokinase Plasminogen Activator-dependent Anthrax Toxin

著录项

引文网络

相似文献

相关主题

期刊订阅